Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design
A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.
Photo illustration—Getty Images
https://fortune.com/img-assets/wp-content/uploads/2025/04/GettyImages-1359391658_89f21f-e1744742272513.jpg?resize=1200,600
2025-04-16 13:00:00
